Nutrasource Pharmaceutical and Nutraceutical Services Inc.

$465,000.00 CAD

≈ 6 Canadians' average pay for a year
Department
National Research Council Canada
Program
Eureka/Eurostar
Recipient country
Canada
Fiscal year
2018-2019
Agreement period
June 1, 2018 – February 28, 2021
Reference
nrc-cnrc:172-2018-2019-Q1-908598

Published purpose

The purpose of this project, EUREKA Network Project E!12216, is to develop the world’s first rapid, point-of-care omega-3 diagnostic device. This device will quickly tell users whether they have sufficient levels of the omega-3 fatty acid docosahexaenoic acid (DHA) in their blood. Project to be executed by Canada based Nutrasource Diagnostics Inc. and their Austria based partner SAICO Biosystems.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions